2:28am

Mon February 3, 2014
Shots - Health News

What's Good For Baby Camels Could Be Good For Human Skin

Originally published on Mon February 3, 2014 3:17 pm

In parts of the Middle East, people drink camel's milk for its nutritional value. It boasts more vitamin C and iron than cow's milk, and it's lower in fat. But in the American Midwest, some people are rubbing camel's milk on their skin — in the form of a skin-care line from Jordan.

Penelope Shihab is the founder of a biotech company in Jordan — and the woman behind the Missouri startup that's working on the skin-care products.

Scientists at Shihab's company in Amman, called MONOJO, have been analyzing the antibodies in camel's milk. These proteins help fight off infections, latching onto foreign pathogens and telling the body's immune system: "intruder alert." They typically degrade in higher temperatures and acidic environments. But the antibodies in camel's milk are stronger.

"We found that those proteins are very, very stable against temperature, high temperature, and against high acidity," Shihab says. "Maybe the reason [is] because the camel can tolerate high temperature in the desert. Some of the scientists say that, but we couldn't confirm any of those suggestions."

Shihab's research team tested these antibodies on acne. The camel antibodies succeed where others fail, says immunologist Khaled Al-Qaoud, because they remain intact longer at the site of inflammation, helping the body's immune system continue to fight the acne.

Al-Qaoud, Shihab's research and development manager, says the results of the study impressed them — so much so that they concocted a camel-milk treatment for the skin condition.

"We use skin formulas, like, for example, gel or cream or serum — any type of formulation — and we put the whey of the camel that contains the antibodies in this formula," Al-Qaoud says.

The Path From Jordan To Missouri

The creams look similar to those found at drug stores: milky white and floral-scented. Shihab says she's commercializing this formula in the U.S. first because Middle Eastern consumers trust American brands.

A colleague directed her to Missouri, a small market where she could learn the ropes of the U.S. biotech industry.

Shihab found a home base for her business in Columbia at the University of Missouri's Life Sciences Business Incubator, where 25 startup companies share lab space and equipment. Shihab's office sits in the corner; a piece of paper with the name "Columbia Biotech" is fixed to the cubicle.

Jake Halliday, president of the incubator, helped Shihab register that name for her American subsidiary that produces the camel's milk skin-care line, now called Skinue. He says Shihab's technology meets the competitive standard to score a spot in the incubator with the other startups.

"[The startups] should have technologies that in turn would become products and services — but mainly products — that have the potential to achieve $20 million in sales a year after about four or five years," Halliday says.

As part of the incubator, Shihab has access to legal counsel, business consultants and other researchers. She says she hopes to have her product approved by the Food and Drug Administration, with Halliday's help.

She also wants to look into its applications in cancer. She has already partnered with two university professors who are looking into increasing the efficacy of the camel-milk antibodies.

In the meantime, Shihab has lined up a supplier in Dubai, a 3,000-camel farm to supply milk for the Skinue line, which now includes a moisturizer and a foot cream. Samples have been distributed to spas and salons across Columbia.

Still, Shihab says she's aware of the challenges she faces breaking into an unfamiliar market.

"It's a male-dominated industry," she says. "Yes, that's true. But when I started in the Middle East there were no men or women [in biotech]. So I am the only woman in the country who's the CEO for a biotech company. That was really very difficult, tough for me."

If sales go well in Missouri, Shihab plans to take her Skinue line into the Chicago and New York markets, and eventually set up production of the line stateside.

Transcript

STEVE INSKEEP, HOST:

In parts of the Middle East, people drink camel milk. It boasts more vitamin C and iron than cow's milk and it's lower in fat. But in Missouri, here in the U.S., some people are starting to rub it on their skin. That's because a Jordanian woman is bringing camel milk to the Midwest in the form of a skin care line.

Kristofor Husted of member station KBIA reports.

KRISTOFOR HUSTED, BYLINE: Today there are seven camels at a farm in Jordan waiting to be milked. That milk will go to a biotech company in Amman called MONOJO. The scientists there analyze the milk of the one-hump mammals looking for three special antibodies.

Antibodies are proteins that help fight off infections. They latch on to foreign pathogens and tell the body's immune system: intruder alert. Typically, these antibodies degrade in higher temperatures and acidic environments. But antibodies in camel milk are stronger.

PENELOPE SHIHAB: We found that those proteins are very, very stable against temperature, high temperature and high acidity.

HUSTED: That's Penelope Shihab, the founder MONOJO in Jordan and the woman behind the startup in Missouri.

SHIHAB: I don't know, maybe the reason because the camel can tolerate high temperature in the desert. So some of the scientists say that, but we couldn't confirm any of those suggestions.

HUSTED: Shihab's research team tested these camel milk antibodies on acne. Immunologist Khaled Al-Qaoud, Shihab's research and development manager, says camel antibodies succeed where others fail because they remain intact longer at the site of inflammation. He says it was the results of their acne study that led them to develop a camel milk treatment.

DR. KHALED AL-QAOUD: We use skin formulas, like for example, gel or cream or serum - any type of formulation - and we put the whey of the camel whey that contains the antibodies in this formula.

HUSTED: The creams look similar to the ones you find at the drugstore. They're milky white and floral scented. Shihab says she's commercializing this formula in the U.S. first because Middle Eastern consumers trust American brands. Her colleague directed her to Missouri, a small market where she could learn the ropes of the U.S. biotech industry.

(SOUNDBITE OF MACHINERY)

JACK HALLIDAY: This is an $80,000 autoclave. Obviously, there's no need for companies each of our companies to buy one if we can put it in a shared resource area.

HUSTED: Jake Halliday heads the University of Missouri's Life Sciences Business Incubator here in Columbia where 25 startup companies share lab space and equipment.

Shihab's office sits in the corner. A piece of paper with the name Columbia Biotech is fixed to the cubical. Jake Halliday says Shihab's product is just what the incubator looks for.

HALLIDAY: They should have technologies that in turn would become products or services, but mainly products, that have the potential to achieve $20 million in sales a year after about four or five years of development of the company.

HUSTED: Shihab calls her product Skinue and is trying to get it approved as an acne treatment by the Food and Drug Administration.

Meanwhile, she's lined up a supplier in Dubai, 3,000 camel-farm to supply milk for the Skinue line, which now includes a moisturizer and a foot cream. Samples have been passed out to spas and salons across Columbia.

Still, Shihab says she's aware of the challenges she faces breaking into an unfamiliar market.

SHIHAB: It's a male-dominated industry. Yes, that's true. But when I started in the Middle East there is no men or no women.

(LAUGHTER)

AL-QAOUD: So I am the only woman in the country who's the CEO for a biotech company. That was really, very difficult. Tough for me.

HUSTED: If sales go well in Missouri, Shihab plans to take her Skinue line into the Chicago and New York markets next, before expanding nationwide.

For NPR News, I'm Kristofor Husted, in Columbia. Transcript provided by NPR, Copyright NPR.